Introduction
Juvenile Macular Degeneration (Stargardt Disease) - Overview
Juvenile Macular Degeneration (Stargardt Disease) - Therapeutics Development
Juvenile Macular Degeneration (Stargardt Disease) - Therapeutics Assessment
Juvenile Macular Degeneration (Stargardt Disease) - Companies Involved in Therapeutics Development
Juvenile Macular Degeneration (Stargardt Disease) - Drug Profiles
Juvenile Macular Degeneration (Stargardt Disease) - Dormant Projects
Juvenile Macular Degeneration (Stargardt Disease) - Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Juvenile Macular Degeneration (Stargardt Disease), H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Companies, H2 2020 (Contd..1), H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020 (Contd..1), H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Juvenile Macular Degeneration (Stargardt Disease) - Pipeline by Alkeus Pharmaceuticals Inc, H2 2020
Juvenile Macular Degeneration (Stargardt Disease) - Pipeline by Alpine Biotherapeutics Corp, H2 2020
Juvenile Macular Degeneration (Stargardt Disease) - Pipeline by Applied Genetic Technologies Corp, H2 2020
Juvenile Macular Degeneration (Stargardt Disease) - Dormant Projects, H2 2020

List of Figures
Number of Products under Development for Juvenile Macular Degeneration (Stargardt Disease), H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Mechanism of Actions, H2 2020
Number of Products by Stage and Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Molecule Types, H2 2020
Number of Products by Stage and Molecule Types, H2 2020

Companies Mentioned
• Alkeus Pharmaceuticals Inc
• Alpine Biotherapeutics Corp
• Applied Genetic Technologies Corp
• Astellas Pharma Inc
• Beam Therapeutics Inc
• Biogen Inc
• Biophytis SA
• Cardax Inc
• Copernicus Therapeutics Inc
• Generation Bio Co
• Grupo Ferrer Internacional SA
• Ichor Therapeutics Inc
• IVERIC bio Inc
• Katairo GmbH
• Kubota Vision Inc
• Lin Bioscience Inc
• Mediphage Bioceuticals Inc
• ProQR Therapeutics NV
• Spark Therapeutics Inc
• Stargazer Pharmaceuticals Inc